Jane Lisko, M.D.
NPI 1619910890 · Specialist · Fridley, MN
Enrolled with Medicare as Practitioner - Micrographic Dermatologic Surgery (mds) · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Jane Lisko, M.D. is a Specialist provider in Fridley, MN (NPI 1619910890).
Provider details
- NPI number
- 1619910890
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 43419 (MN)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,655 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 519 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 226 | $91 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 156 | $48 |
| Destruction of Skin Growth, 1-14 Growths17110 | 150 | $110 |
| Removal and Microscopic Exam of Growth of Head, Neck, Hands, Feet, Or Genitals, 1-5 Tissue Blocks17311 | 118 | $688 |
| Biopsy of Related Skin Growth, First Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Mupirocin | 149 | 117 |
| Ketoconazole | 94 | 41 |
| Triamcinolone Acetonide | 50 | 42 |
| Valacyclovir Hclbrand: Valacyclovir | 43 | 19 |
| Fluorouracil | 42 | 38 |
| Fluocinonide | 39 | 26 |
| Betamethasone Dipropionate | 32 | 14 |
| Cephalexin | 26 | 15 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$173 across 11 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-14
- Last updated
- 2011-02-16
Frequently asked questions
- What is Jane Lisko's NPI number?
- Jane Lisko's National Provider Identifier (NPI) is 1619910890, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Jane Lisko's specialty?
- Jane Lisko is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Jane Lisko located?
- Jane Lisko's practice location on file with NPPES is 7205 University Ave Ne, Fridley, MN 55432-3134.
- What is Jane Lisko's phone number?
- The practice phone number listed in the NPPES registry for Jane Lisko is (763) 571-4000.
- Does Jane Lisko accept Medicare?
- Jane Lisko is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Jane Lisko's NPI active?
- Yes — Jane Lisko's NPI (1619910890) is active in the NPPES registry as of the last update on 2011-02-16.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.